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ABSTRACT 
Background  
T cells have been shown to play a role in etiopathogenesis of periodontal 
disease. B7-H3, a costimulatory molecule is found to be associated with 
regulation of T cell function in other chronic inflammatory diseases.
 
Materials & methods 
Gingival samples were taken from 2 groups of patients (group A -
periodontal health and group B- periodontal disease). These were paraffinised 
and processed to carry out immunostaining to identify B7-H3 expression. The 
slides were then examined under light microscope to assess the positive 
staining in epithelium and connective tissue. The intensity of positive staining 
in epithelium and the number of positive cells in the connective tissue were 
evaluated. Statistical analysis was done using kappa analysis and independent 
‘t’ test. 
Results  
Kappa analysis revealed good inter-examiner agreement for both the 
groups (group A - 0.718; group B - 0.797). Intensity of staining in the 
epithelium ranged from intense to moderate for both the groups. In the 
connective tissue there was a statistically insignificant decrease                           
(p value- 0.415) in the number of positive cells from group A (mean labeling 
index- 50.28±26.09) to group B (mean labeling index-  41.37±25.29). 
Conclusion  
B7-H3 expression demonstrated a statistically insignificant decrease in 
disease as compared to health. 
Keywords :  
 B7-H3, Periodontitis, Immunohistochemistry. 
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INTRODUCTION 
 Periodontal disease is multifactorial in nature, where the chronic 
inflammation is initiated in response to bacteria eventually resulting in 
destruction of tooth supporting structures. This unpredictable but exacerbated 
host response has been considered responsible for the tissue destruction seen 
in periodontitis.
17
 T cells have been documented to play a central role in 
modulating host response against periodontopathogenic bacteria.
119
 
T cells have demonstrated greater ability to recognise protein antigen in 
periodontopathogens when compared to other surface components. T cell 
activation includes antigen recognition, processing and costimulation. The 
antigen processing is a function that is carried out by both professional and 
non-professional antigen presenting cells (APC). 
Costimulation is carried out by the interaction of B7 ligands on the APC 
to its corresponding receptor on the T-cell. This process of costimulation 
ensures that T cell apoptosis is prevented, thereby ensuring that the entire 
repertoire of T cell cytokines is released.
41,56,72,22,45
  The costimulation that has 
been identified in periodontal disease belongs to the B7-1 & B7-2 members of 
B7 family.
46
 They carry out costimulation through binding to CD28 and 
inhibition by binding to CTLA-4. 
In recent years the role of B7-H3, a newly identified member of B7 
family of costimulatory molecules has been proposed to contribute in the 
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etiopathogenesis of various non-linear inflammatory diseases. Several studies 
have reported either an increase or decrease in B7-H3 expression.
23,73,147
 
In addition to immune cells, human B7-H3 has been shown to be 
expressed by non-immune cells.
61,134
 Early studies reported that the binding of 
B7-H3 to its counter-receptor on T cells leads to T cell activation.
23
 However 
other studies have reported an inhibitory role for B7-H3 in T cell 
activation.
134,135,147
 
The clinical course of periodontal disease is characterised by short 
bursts of disease activity and long periods of quiescence. The factors that have 
been proposed to play a role are not yet well defined. They are thought to be 
related to a change in quantity or quality of periodontopathogenic bacteria 
and/or host response. The host response in turn is thought to be determined by 
preponderance of either Th1 or Th2 lesion.
127,38
 Even so, the factors that 
upregulate the inflammatory process or T-helper cells are better defined when 
compared to inhibitory mechanism. 
There is as yet limited information about the nature of signals that 
inhibit or regulate the T-helper cell response in periodontal disease. It has been 
postulated that B7-H3 might play a regulatory role in T-helper cell response, 
similar to other chronic inflammatory lesions such as rheumatoid arthritis. 
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AIMS & OBJECTIVES 
 
The aim of the present study was  
 To evaluate if gingiva expresses B7-H3 (immunoregulatory/ 
costimulatory molecule)   
  To compare B7-H3 expression between healthy and diseased 
gingival tissue samples. 
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REVIEW OF LITERATURE 
 Periodontitis is a chronic, non-resolving inflammatory disease of 
multifactorial etiology characterized by destruction of tooth supporting 
structures in susceptible individuals.
47
 Disease progression is due to a 
combination of factors such as genetics, environment and the host immune 
system. These factors may modify the pathway by which infectious agents 
cause inflammation and therefore can determine whether microbial infection 
will lead to periodontal destruction or to periodontal stability.
63
 
 The destruction of bone and connective tissue, including collagens, 
proteoglycans, and other components of the extracellular matrix does not 
follow a linear pattern. The tissue destruction is constantly being adjusted by 
the host-bacterial interactions resulting in periods of exacerbation and 
quiescence. In diseased periodontal tissues there is a dense mononuclear 
inflammatory infiltrate between the bacteria and the tissues.
111 
This infiltrate 
contains all of the cellular components necessary to control the infection, 
including abundant T lymphocytes
43,140 
as well as numerous B cells and 
plasma cells.
128
 The central role played by T cells in regulating immune 
response to periodontal disease have been well-documented.
38,113,127
 
GINGIVA 
 The oral epithelium represents a dynamic physical and chemical 
barrier against the microbial biofilm.
12
 Histologically, healthy gingival tissues 
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comprise keratinocytes and also immune cells like dendritic cells,
26,36,69,70
 
polymorphonuclear leukocytes,
125 
lymphocytes and mononuclear 
phagocytes.
125
 
 Cells of junctional epithelium secrete cytokines including chemotactic 
cytokines (IL-8
145,146
 and cytokine-induced neutrophil chemoattractant-2
101
), 
as well as proinflammatory cytokines (IL-1 and tumor necrosis factor-α101). 
Furthermore, cells of the junctional epithelium and their resident leukocytes 
contribute to host defense by expression of antibacterial peptides including 
calprotectin,
107
 α- and β- defensins149,24,86 and cathelicidin LL-37.34 
Vankeerberghen A et al (2005)
149
 demonstrated an upregulation of                     
β-defensins and IL-8 by polymorphonuclear leukocytes, in tissues of patients 
with chronic periodontitis.
86 
Studies by Bissell J (2004)
10  
and Lundy 
FT(2005)
88 
stated that healthy tissues appear to have high concentrations of 
defensins, indirectly supporting their role in homeostasis of the gingival sulcus 
in health . 
 Emerging evidence indicates that keratinocyte activation is a result of 
interaction between periodontal bacteria and keratinocytes, leading to release 
of a variety of inflammatory mediators.
39
 These stimuli may act locally to 
transmit the inflammatory message in a centripetal direction towards the 
subepithelial microvessels and thereby induce an inflammatory reaction.
75
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Antigen presenting cells 
 The microbe must first be recognized and captured in the skin/mucosa 
by APC. For this they possess a unique array of antigen recognition and 
capture receptors including the toll-like receptors and C type lectin receptors. 
The antigen must then be processed into smaller peptides. Following which, 
the peptides must then be packaged with molecules called major 
histocompatibility complex (MHC) and presented to the T cells.
129,150
  
 APCs are further classified as professional APC (dendritic cells, 
macrophages and B-cells) and non- professional APC (keratinocytes and 
gingival fibroblasts). The professional APCs express MHC class II molecules 
and costimulatory molecules.
31,5
  
Gingival keratinocytes 
 Renne J et al (2010)
120
 and Chung Y et al (2009)
25 
reported the 
constitutive expression of IL-1α on keratinocyte which has been known to 
promote T cell responses. It has autocrine actions which include upregulating 
MHC class II expression and, stimulation of cytokine and chemokine 
production. Besides, it also has juxtacrine actions to activate neutrophils, 
monocytes and T cells which infiltrate under inflammatory conditions.
132
 It 
has been reported that IL-1α was a general amplifier of T-cell responses in 
several epithelial tissue immune responses.
18,105,154  
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Dendritic cells 
 They occupy a unique niche in the innate immune system by serving as 
a bridge to the adaptive immune system. They do this by capturing microbes 
and their antigens while in the immature state and stimulating a T cell 
response to these antigens in their mature state. They enable in priming naive 
helper/cytotoxic T cells to undergo clonal expansion.
5,6,31,57
 
 To stimulate naive T cells that have never encountered the antigen 
before, additional signals (i.e. costimulatory signals) which are expressed by 
dendritic cells are required. Dendritic cells express class II MHC molecules 
also costimulatory molecules CD80 and CD86.
31,6
 
 In peripheral tissues of humans, three major types have been described, 
including two of myeloid origin – Langerhan’s cells and interstitial dendritic 
cells and the third of lymphoid origin- plasmacytoid dendritic cells.
31
 Others 
include follicular dendritic cells (restricted to primary B-cell follicles)
76
 and 
those developed from in vitro dendritic cell culture systems (cultured either 
directly from CD34+ hematopoietic progenitors
20,21
 or precursors 
differentiated from CD34+ progenitors).
69,143 
CD1a+ Langerhan’s cells have 
been found to increase in number in the epithelium with gingivitis,
69
 
experimental gingivitis
106,151 
and periodontitis.
26,69 
It is speculated that these 
Langerhan’s cells are mobilized and matured in response to inflammatory 
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cytokines and pathogen associated molecular patterns from oral mucosal 
pathogens.
69,30,32
 
 
Macrophages 
 Circulating monocytes can migrate to any site of infection or 
inflammation where they transform into macrophages which phagocytose and 
kill microbes. Macrophages constitutively express low levels of MHC class II 
molecules and costimulators. In the presence of effector Th1 cells which 
secrete higher levels of IFN-γ and CD40L macrophages carry out antigen 
presentation. CD40-CD40L binding ensures that macrophages present antigen 
to T cells.
1
  
B-cells 
 Its antigen presentation differs from other profesional APC (dendritic 
cells, macrophages). They engulf antigen using immunoglobulin receptor 
referred to as the B cell receptor. The antigen is reduced to peptides and 
transported to B cell surface for presentation to CD4+ T cells. For clonal 
expansion and costimulation apart from interaction of BCR and antigen, 
binding of CD40 (B cell) to CD154 (activated T cell) is essential.
8
  
Gingival fibroblasts 
 Fibroblasts can modulate immune cell behaviour by conditioning the 
local cellular and cytokine production. Fibroblast activation leads to 
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production of cytokines, chemokines and prostanoids such as                
prostaglandin E2.
133
 Fibroblasts can also regulate the behaviour of 
haematopoietic cells present in damaged tissue via CD40–CD40L interaction, 
which leads to the activation of the NF-kB family of receptors. This causes 
fibroblasts to synthesize high levels of IL-6, IL-8, cyclooxygenase-2 and  
hyaluronan.
166,112
 This mechanism is similar to the crosstalk that occurs 
between lymphocytes and antigen presenting cells and suggests that it may 
provide crosstalk between fibroblasts and leukocytes.  Brouty-Boye D et al 
(2000)
15
, Hogaboam C.M. et al (1998)
62
 and Pap T et al (2000)
112
 reported 
that fibroblasts taken from diseased tissues display a fundamentally different 
phenotype compared with fibroblasts taken from  normal tissues at the same 
anatomical site.  
ROLE OF T CELLS IN PERIODONTAL DISEASE 
 T cells are involved in nearly all immunoregulatory interactions both in 
vivo and in vitro
118
 and a delicate balance between effector and regulatory 
subsets is required for immune homeostasis.
119
 
T helper cell subsets 
 Mosmann et al (1986)
103
 first reported that mouse T cell clones can be 
classified as two functional subsets based on their cytokine profile as type I 
helper T cells (Th1) and type 2 helper T cells (Th2). The 2 distinct CD4+ 
helper T-cell subsets are induced following infection whose balance 
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determines what kind of adaptive immune response is utilized to eliminate 
infection.
103 
Th1 cells preferentially secrete interleukin-2 (IL-2), interferon- γ 
(IFN-γ)103 and result in cell mediated immunity.27 They increase the ability of 
macrophages to kill both intracellular and extracellular pathogens and also 
mediate delayed-type hypersensitivity reactions.
121
 Th2 cells secrete IL-4,5,6 
and 13
103
 and induce humoral immunity resulting in B-cell development.
104
 
D’Andrea A et al (1993),33 Ohmori et al (1997)109 showed that once either 
Th1 or Th2 cells become dominant they can dampen the development of the 
other subset, as a result making it difficult to change the immune response 
pattern. 
Factors influencing Th subsets 
 Differentiation of Th1 and Th2 T-cell subsets is determined during 
priming and is influenced by a number of factors, including the cytokine 
environment, the antigen itself, antigen dose, the route of administration, the 
nature of the antigen presenting cells and costimulatory molecules.  
1. Antigen binding 
 The huge spectrum of antigen diversity of T cells is achieved by 
structural variation of TCR. TCRs consist of two polypeptide chains, α and β 
or γ and δ chains.  Diversity in antigen recognition by T cells is generated in 
part by the recombination of germ line V, D, J and C gene segments of TCR β 
and δ chain and V, J and C of TCR α and γ chain.35 Boyton RJ (2002)13 
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studied the impact of TCR selection and structure in Th1 and Th2 lines and 
clones with fixed peptide specificity and class II restriction. The Th2 clones 
tended to use TCR complimentarity–determining region (CDR) 3α loops than 
their Th1 counterparts. Molecular modeling of Th1- and Th2 – derived TCR 
showed that Th2 CD3α comprised larger side chain residues than Th1 TCR. It 
was proposed that under Th2 polarizing conditions, there was a trend for 
CD4+ T cells to have elongated TCR CD3α loops, which are predicted to alter 
TCR binding and reduce contact at other interfaces, possibly impeding TCR 
triggering. Boyton et al (2002)
13
 concluded that either the elongated receptor 
was lost during selective expansion of Th1 cells or that selection of the Th2 
line was compatible with expansion of cells bearing  either type of receptor, 
with the elongated form as the preferred receptor. 
2. Cytokines  
 Boyton &  Altmann  (2002)
14
 have proposed that differential selection 
from the available pool of specific TCR occurs during Th1 or Th2 
development. They also suggested that programming to select for cells to 
become either Th1 or Th2 T cells may come from local factors such as 
cytokine or chemokine milieu. They also stated that while many factors 
determine the polarization of T cells any one factor can override the changes 
initiated by any other factor.
14
  
 Iezzi G (1999)
65
 reported that in the presence of IL-12, a short T cell 
receptor stimulation has been shown to induce Th1 polarization, IL-12 
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exerting its effect during and after TCR signaling. Th2 polarization, on the 
other hand required prolonged TCR signaling and IL-4 was effective only 
when present during TCR triggering. These authors concluded that duration of 
TCR stimulation was crucial in influencing Th1/Th2 polarization. 
3. Antigen presentation 
 The regulation of the immune response may reside at the level of 
antigen presentation such that presentation by professional antigen-presenting 
cells (such as dendritic cells and macrophages) results in stimulation of 
destructive cytokines while presentation by nonprofessional antigen-
presenting cells (such as epithelial or endothelial cells) results in anergy and 
no tissue destruction.
59,142 
The mechanism of this anergy is unknown, but it is 
well established that junctional and pocket epithelial cells express major 
histocompatibility complex class II antigens
127
 and hence could be capable of 
antigen presentation, which results in anergy and possible apoptosis of the Thl 
cells, and thereby allow cells with a Th2 cytokine profile to emerge. 
Endothelial cells, which in humans constitutively express major 
histocompatibility complex class II, could also present antigen leading to 
anergy.
142
 
 Where B7 ligands are limited, low levels of CD152 with its greater 
affinity and avidity for B7 may induce signals which predominate and inhibit 
T cell responses. With increased expression of B7, initially on dendritic cells 
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and subsequently on activated B cells, CD28 signals may predominate, 
resulting in T cell activation.
22 
 T cells express CD28 rather than CD152 in periodontal disease 
specimens.
46,74
  CD28+ T cells were found to increase with increasing 
numbers of B cells suggesting T and B cell interactions with increasing 
inflammation.
46
 
 CD28/B7 interactions may influence cytokine profiles, with Th1 
clones being more dependent on B7 than Th2 clones.
45,66 
Th2 clones on the 
other hand which use IL-4 as their autologous growth factor, can be activated 
without CD28 costimulation,
99
 indicating that activation of differentiated Th2 
cells may require other costimulatory molecules.
45
 However B7/CD28 binding 
is necessary to make these cells responsive to IL-4. CD28 increases 
responsiveness to IL-4 through an IL-1 dependent route, i.e., CD28 
costimulation is mediated by IL-1 induction in these cells. Therefore, CD28 is 
required for activation and proliferation of Th1 and Th2 cells although the 
mechanism may differ.
99
  
Th1/Th2 paradigm  
 Seymour et al (1993)
127
 proposed that in non-susceptible individuals 
predominantly Th1 subsets are found leading to cell mediated immunity.   
IFN-γ expression is upregulated and protective antibodies maybe produced. 
However in individuals susceptible to periodontal breakdown Th2 subsets 
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predominate. They produce cytokines required for B cell proliferation and 
differentiation leading to polyclonal B cell activation and upregulation of non-
protective antibodies along with IL-1 production by B cell. 
 Ebersole and Taubman (1994)
38
 carried out adoptive transfer 
experiments using the Th2 clone A3. They reported that Th2 cells abrogate 
periodontal disease and Th1 cells aid in disease progression.  
 Pilon M et al (1991)
113
 demonstrated decreased Th1 cytokines in the 
gingival crevicular fluid of periodontitis sites. Fujihashi K et al (1991)
42
 
reported decreased Th1 cytokines in gingival mononuclear cells of 
periodontitis sites. Sigush B et al (1998)
131 
and Gemmell E (1994)
48 
reported 
decreased Th1 cytokines in peripheral blood mononuclear cells from 
periodontitis patients stimulated with mitogens, P.gingivalis and F.nucleatum  
respectively. Aoyagi  T  et al (1995)
2
, Bartova J et al (2000)
7
, Yamazaki          
K et al (1994)
158 
 reported increased Th2 responses in peripheral blood from 
patients with periodontitis . Lappin DF et al (2001)
78
, Tokoro Y et al (1997) 
and Yamazaki K et al (1994)
158
 reported increased Th2 responses in gingival 
tissues. Manhart SS et al (1994)
95
 and Reinhardt RA et al (1989)
117 
reported 
increased Th2 responses in extracted gingival mononuclear cells and gingival 
crevicular fluid respectively. All these studies support the hypothesis that Th1 
cells are associated with a stable lesion and a Th2 response with disease 
progression. However, Ebersole JL et al (1994),
38
 Salvi GE (1998),
124
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Takeichi O (2000)
140 
reported a predominance of Th1-type cells or reduced 
Th2 responses in periodontally diseased tissues. 
 Fujihashi K et al (1994)
44
 and Prabhu A et al (1996)
115
 have 
suggested the involvement of both Th1 and Th2 cells in sites with 
periodontitis. mRNA for both Th1 and Th2 cytokines has been demonstrated 
by these studies in periodontally diseased tissues.  
Activation of T cells 
 Antigen recognition is the first step in the clonal expansion and 
activation of antigen-specific T cells. They recognize peptide antigens via the 
TCR. On the surface, TCR is expressed as a complex with a CD3 molecule 
whose δ chains have cytoplasmic tails capable of transmitting an activation 
signal derived from antigen binding to TCR.
94
 CD4 and CD8 molecules act as 
coreceptors with TCR.
9
 For T cell to recognize an antigen, the antigen has to 
be engulfed by APC, processed into antigen peptides and presented on the cell 
surface by binding to peptide binding groove of MHC. The TCR recognizes 
and binds to the antigen bound MHC presented by APC.
129,150
 This provides 
the 1st signal for T cell activation leading to proliferation, differentiation and 
activation of CD28. The second signal is non-specific resulting from binding 
of APC expressed costimulatory ligands (belonging to B7 family) to its 
receptor on T cell which is important for T cell survival and function. 
However T cells cannot be activated by only an antigen signal.  Without 
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costimulatory signals from costimulatory molecules such as CD28
68,71
 and the 
CD40L,
3
 antigen signals make T cells anergic rather than activate.  It is now 
accepted that optimal activation of T cells requires both costimulation and 
TCR engagement.
 41,56,72,22,45 
   
SECONDARY SIGNALING MOLECULES 
 Costimulatory interactions between the B7 family ligands expressed on 
antigen-presenting cells (APC) and their receptors on T cells play critical roles 
in the growth, differentiation, and death of T cells.
41,56,72,22,45
 
CD28 & CTLA4 
  A costimulatory signal (signal 2) occurs through the CD28 molecule, 
which is recruited to the immunological synapse following TCR ligation and 
is provided by B7-1 or B7-2. Like the MHC, the B7 proteins are expressed by 
APCs. The costimulatory signal serves to induce T-cell production of 
interleukin (IL) -2.  IL-2 acts in an autocrine ⁄ paracrine fashion on the T cells 
and is obligatory for their survival and differentiation into effector cells.
114
 
Without the costimulatory signal, signal 1 from the TCR by itself induces            
T cells to become tolerant to their cognate antigen instead of activated.
67,50,51
 
Both the TCR and CD28 are constitutively expressed on most naıve T cells, 
such that the T cell is ready to respond to antigen as presented by an            
MHC-expressing APC.   
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 Cytotoxic T lymphocyte antigen 4 (CTLA-4) functions to inhibit T-cell 
responses and thus has opposing activities to CD28. Binding of B7-1 or B7-2 
with CTLA-4, a homolog of CD28, may inhibit T cell responses by delivering 
a putative negative signal.
22,16,77,152,153
     
B7 Molecules 
 B7 family comprises of immunomodulatory proteins required for fine-
tuning immune responses in addition to the primary signal provided by 
peptide-MHC complex. Several authors have reported that costimulatory 
interactions between the B7 family ligands expressed on antigen-presenting 
cells (APC) and their receptors on T cells are essential for the growth, 
differentiation, and death of T cells.
41,56,72,22,45
 
 These mediate cell-to-cell interaction by ligating surface associated 
receptors belonging to the CD28 family, expressed by T- lymphocytes. 
Members of the B7 family include – B7-1, B7-2, ICOS-L, B7-H1 (PD-L1), 
B7-DC(PD-L2), B7-H3 and B7-H4. They belong to the immunoglobulin (Ig) 
superfamily of type I transmembrane proteins.  
B7-1 & B7-2 
 B7-1 (CD80) and B7-2 (CD86) are the best-described B7 proteins. 
They interact with the co-stimulatory receptor CD28 and the inhibitory 
receptor CTLA-4.
71,54
 B7-1 and B7-2 are expressed mainly by professional 
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antigen presenting cells which are activated monocytes, B cells and dendritic 
cells.
71,54
 
  Macrophages constitutively express low levels of CD86. CD80 is 
induced after treatment with interferon-γ. CD86 expression is also low on B 
cells until activation, which induces a rapid up-regulation of these molecules.
66
 
Gemmell E et al (2001)
46 
reported that the percentage of CD86+ B cells and 
macrophages has been shown to be significantly higher than the percentage of 
CD80+ macrophages in gingival tissue sections. Mahanonda R et al (2002)
92
 
showed that CD86 was up-regulated mostly on B cells isolated from 
periodontitis lesions. They also reported that a number of 
periodontopathogenic bacteria including P. gingivalis up-regulated CD86 on B 
cells in vitro.   
 Azuma M et al (1993)
4 
has reported the expression of B7 molecules 
by activated human peripheral blood T cells, CD4 and CD8 clones and natural 
killer clones. Hirokawa et al (1995)
60
 suggested that B7 molecules functioned 
as co-stimulatory molecules on T cells and helped in clonal expansion of 
activated T cells. Another study has shown that memory CD4 cells express 
CD86 while naive CD4 cells do not. Naive T cells expressed CD80 after co-
stimulation with CD86 and T cell receptor ligation.
55
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B7-H1 (PD-L1) & B7-DC (PD-L2) 
 B7-H1
37
 and B7-DC
148
 (also referred to as PDL-1 and PDL-2), are 
ligands for PD-1, an inhibitory receptor on T cells.
79
 B7-H1 (PD-L1) and          
B7-DC (PD-L2) have been identified in both lymphoid and several 
nonlymphoid tissues, as well as in several tumor cell lines, and are putative 
inhibitory co-stimulatory ligands.
79
 Interaction of these ligands with the 
counter-receptor PD-1 can result in inhibition of T and B cell responses.
108 
 
PD-1 receptor is thought to mediate immunological self-tolerance. B7-DC can 
inhibit lymphocyte activation, or, like B7-H1, co-stimulate lymphocyte 
function through an as yet ill-understood mechanism.
148,79
 However, several 
authors have found that binding of PD-L1 and 2 to PD-1 is costimulatory on  
T cells.
37,148,130,141,84
 
B7-H2 & ICOS 
 B7-H2 is detected on B cells and macrophages, and is a ligand for the 
inducible costimulatory (ICOS) expressed on antigen-primed T cells. 
Costimulatory signals via ICOS activate memory T cells with some preference 
for Th2 responses.
155,28,97,98,64
  Yoshinaga SK et al (1999)
160 
reported its 
expression by activated and resting memory T cells. Several authors have 
reported that it is constitutively expressed by B lymphocytes and is induced by 
tumor necrosis factor α on nonlymphoid cells.82,155,160,139  Chapoval AI et al 
(2001)
23 
has shown that engagement of B7-H2 results in activation of T-helper 
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memory cells with a bias production of  Th2 cytokines, such as IL-4 and            
IL-13.
81
 
B7-H3 
 Chapoval AI et al (2001)
23 
discovered B7-H3, a B7 homologue, in the 
laboratory of Lieping Chen. They originally described B7-H3 as a                         
2-Immunoglobulin like domain. This was supported in murine studies done by 
Sun M et al (2002)
136
 and Ling V et al (2003).
83
 Mouse B7-H3 is located on 
chromosome 9, which shares 88% identity and 93% similarity with the human 
molecule. Human B7-H3 is encoded on chromosome 15. Steinberger             
P et al (2004)
134  
reported that the human B7-H3 has a 4 Ig-like structure. 
They proposed that the 4 Ig structure could be due to a duplication of the locus, 
which encodes B7-H3-IgV and -IgC exons. 
 Chapoval AI et al (2001),
23 
Sun M et al (2002),
136 
Zhang                   
GB et al (2005)
165
 and  Steinberger P et al ( 2004 )
134
 have reported its 
expression  is induced in T cells, B cells, monocytes, dendritic cells (DCs) and 
some tumour cell lines. B7-H3 is also found on non-professional APCs 
including fibroblasts, fibroblast-like synoviocytes, and epithelial cells.
61
  
 At the transcriptional level, B7-H3 is found in most organs.
23,136,165
 At 
the protein level, B7-H3 is found in human liver, lung, bladder, testis, prostate, 
breast, placenta, and lymphoid organs. Hofmeyer KA et al (2008)
61
 suggested 
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that due to its posttranscriptional regulation different expression patterns have 
been observed between B7-H3 mRNA and protein.  
 Zhang G et al (2008)
163
 demonstrated that human soluble B7H3  
(sB7-H3) was cleaved by MMPs from the surface of activated T cells, 
monocytes and monocytes-derived dendritic cells which was able to bind its 
receptor on activated T cells. 
 Zhang G et al (2010)
164
 reported that sB7-H3 on binding to 
costimulatory receptors on monocytes /macrophages results in secretion of 
proinflammatory cytokines. 
 Zang X et al (2003)
161
 and Hashiguichi et al (2008)
58
 reported that 
triggering receptor expressed on myeloid cell (TREM)-like transcript 2   
(TLT-2, or TREML2), is the costimulatory receptor for B7H3 particularly in 
CD8 T cells. However, Leitner et al (2009)
80
 showed that B7-H3 is not a 
costimulatory ligand for TREML-2 receptor. Also several authors have 
reported that B7-H3 is an inhibitory molecule. This function has been reported 
to be mediated by its binding to another receptor.
61
  
Cell culture studies  
B7-H3 coinhibitor 
 Mahnke et al (2007)
93
 reported that on contact between dendritic cells 
(DC) and CD4+CD25+regulatory T cells (Tregs) there was an upregulation of 
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B7-H3 molecule on DC surface. Also the number of MHC-peptide complexes 
were decreased.  
 Steinberger P et al (2004)
134 
reported B7H3 is expressed by immature 
and mature monocyte derived dendritic cells. They found that it binds to an 
inhibitory receptor on T cells as its binding does not stimulate T cell 
proliferation. 
Murine  studies 
B7-H3 costimulator 
 Chapoval AI (2001)
23 
reported B7-H3 Ig fusion protein increase 
CD4+ and CD8+ T cells and selectively stimulates IFN-γ production.  
 Hashiguichi M et al (2008)
58
 reported that binding of B7-H3 to           
TLT-2 results in proliferation of CD8+ T cells and upregulation of IFN-γ 
production by CD8+ T cells. 
B7-H3 coinhibitor 
 Prasad DV et al (2004)
116
 reported that it is expressed by all 
professional APCs and a minor subset of CD4+ and CD8+ T cells. It was 
found to inhibit transcriptional factors AP-1, NFAT and NF-κB which regulate 
T cell activities. Murine B7-H3 was found to inhibit T-cell activation and 
effector cytokine production. 
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Human studies 
B7-H3 coinhibitor 
 Ling V et al (2003)
83
 reported that B7-H3 downregulates CD4+ T cell 
proliferation and effector cytokine production. 
B7-H3 EXPRESSION IN SYSTEMIC DISEASES 
 Animal studies 
B7-H3 coinhibitor 
 Suh WK et al (2003)
135
 detected that B7-H3 deficient mice developed 
more severe airway inflammation and the lesions had predominantly Th1 
cells. They reported that B7-H3 is upregulated in the presence of IFN-γ and 
downregulated in the presence of IL-4. 
  Prasad DV et al (2004)
116
 found that when B7-H3 deficient mice 
were exposed to autoimmune encephalomyelitis, it was exacerbated. 
Human studies 
B7-H3 costimulator 
 Kim J et al (2005)
73
 found that B7-H3 was the most abundant 
costimulatory molecule detected by flow cytometry on cultured respiratory 
tract epithelial cells. Engagement of B7-H3 ligands results in proliferation of 
CD4+ and CD8+T cells, a bias toward Th1 cytokine production, and primary 
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cytotoxic T cell activation. They concluded that the presence of B7 homologs 
on epithelial cells may play a role in driving expression of the Th1 and Th2 
cytokines observed in asthma and CRS. 
B7-H3 coinhibitor 
 Tran et al (2008)
147
 found that B7-H3 expression was associated with 
FLS rich areas and was in close proximity to T cells in the RA pannus. The 
expression of B7-H3 was found to be constitutive and uninfluenced by 
immunoregulatory cytokines. They suggested that B7-H3 could be an 
important signaling molecule between FLS and T cells.  They reported that 
B7-H3 binds to inhibitory receptor on unstimulated T cells and activating 
receptor on cytotoxic T cells. 
Cancer immunity 
In vitro 
B7-H3 costimulator 
 Studies have been carried out with commonly used human cancer lines 
in the laboratory, such as HL-60 promyelocytic leukemia, K562 myelogenous 
leukemia, SW480 colon adenocarcinoma, A549 epithelial lung 
adenocarcinoma, and G361 melanoma. They were found to express high level 
of B7-H3 mRNA.
23
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Animal Studies 
B7-H3 coinhibitor 
 Sun X et al (2003),
137
 Luo L et al (2004),
90 
 Luo L et al (2006)
89 
and 
Lupu CM et al (2006)
91
 reported that in mouse cancer models, ectopic 
expression of B7H3 leads to activation of tumor-specific CTLs that are able to 
slow, tumor growth or even completely eradicate tumors. 
Human studies 
B7-H3  costimulator 
 Many human cancers have been found to naturally express B7-H3. 
Subsequent studies demonstrate that prostate cancer, non-small-cell lung 
cancer, gastric carcinoma, ovarian cancer, renal cell carcinoma, urothelial cell 
carcinoma, and neuroblastoma, also express B7-H3.
19,23,29,138,162,156,123,11
   
  Crispen PL et al (2008)
29
 showed that B7-H3 expression by either 
clear cell renal cell carcinoma (RCC) or the tumor vasculature was found to 
significantly associate with an increased risk of death from RCC.  Likewise, a 
marked increase in B7-H3 expression was observed in majority of prostrate 
cancers, and statistically correlated with poor prognosis.
122
 Also in case of 
urothelial cell carcinoma,
11
 non small-cell lung cancer,
157
 and  pancreatic  
cancer  immunohistological studies show that increase in  B7-H3 expression 
correlates with cancer progression. Castriconi R et al (2004)
19
 reported that 
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4Ig B7-H3 protects tumor cells in bone marrow (especially neuroblastoma) 
from natural killer cell (NK cells) mediated killing. They reported that binding 
of 4IgB7-H3 to its receptor on NK cells results in inhibition of its actions.   
B7-H3 coinhibitor 
 Studies in gastric carcinoma correlates elevated B7-H3 expression by 
cancer with an increased survival rate in patients.
162,156
 Loos et al (2009)
85
  
examined  B7-H3 expression by immunohistochemistry in pancreatic cancer  
tissue specimens from  68 patients who underwent surgical resection. They 
found that abundant expression of B7-H3 by tumor cells in pancreatic cancer 
was associated with increased expression of cytotoxic T cells, and correlated 
with anti-tumor immune response.  
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MATERIALS AND METHODS 
STUDY POPULATION 
 The study population comprised of randomly selected patients from 
those attending the Dept. of Periodontics, Ragas Dental College and Hospital, 
Chennai. The study protocol was approved by the Institutional Review Board 
of Ragas Dental College. Prior to conducting the study, informed consent was 
obtained after explaining the study protocol to the patients. A total of                    
30 patients were randomly selected for the study.  
The selected patients were divided into two groups: 
Group A: 15 periodontally healthy subjects (5 males & 10 females of age              
20-50 years (mean 35.6 years)) exhibiting no signs of periodontal disease as 
determined by the absence of  bleeding on probing (BOP) and clinical 
attachment loss (CAL) , with  probing depth (PD) ≤ 3mm. 
Group B:  15 subjects with chronic periodontitis (7 males & 8 females of age 
20-65 years (mean 45.7 years)) exhibiting PD 5 mm, CAL ≥ 3 mm and 
presence of BOP in at least six sites.  
Inclusion criteria: 
1. Patients who were systemically healthy. 
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2. Patients who were non-smokers. 
3. No history of anti-microbial therapy for the past three months.   
Exclusion criteria:  
1. Patients who had received periodontal treatment within the previous 6 
months.  
2. Patients with other dental problems such as pulpal diseases. 
GINGIVAL TISSUE SAMPLE COLLECTION  
 Gingival tissue samples were obtained from periodontally healthy 
patients (Group A) during crown lengthening procedure, by placing an 
external bevel incision 1mm from gingival margin (1*3 mm tissue). 
 In patients with chronic periodontitis (Group B) gingival biopsy was 
obtained, one week after scaling and root planning (SRP). An internal bevel 
incision was placed 1mm from gingival margin (1*3 mm tissue) and tissue 
was excised during the modified Widman flap procedure. 
 The obtained gingival tissue specimens were fixed with 10% neutral 
buffered formalin. Prompt fixation was carried out to ensure the preservation 
of tissue architecture and cell morphology. The tissues were paraffin 
embedded within 48 hours, to avoid degradation of the antigens. 
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ARMAMENTARIUM FOR IMMUNOHISTOCHEMISTRY 
PROCEDURE 
Instruments/Equipments   
1. Aluminium foil 
2. Microscopic slides  
3. Detergent solution  (Laxbro) 
4. Autoclave 
5. Beakers 
6. Coplin jars 
7. Cover slips 
8. Electronic timer 
9. Slide warming table 
10. Light microscope 
11. Measuring jar 
12. Micropipettes 
13. Rectangular steel trays with glass rods 
14. Refrigerator 
15. Sterile gauze 
16. Tooth forceps 
17. Diamond pencil 
18. Weighing machine (Sartorius) 
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19. Coulter’s chamber  
Reagents: 
1. Distilled water 
2. Acetone 
3. Xylene 
4. Absolute alcohol 
5. Alcohol 70% 
6. Alcohol 50% 
7. Hydrogen peroxide 3% 
8. EDTA buffer  (pH8.0) 
9. Phosphate buffered saline (pH 7.0) 
10. Harris’s Hematoxylin 
11. DPX 
ANTIBODIES:  
Primary Antibody: 
 R&D systems, Human B7-H3 Affinity Purified Polyclonal Antibody 
(100UG); Catalog Number AF 1027, Minneapolis , USA. 
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Immunohistochemistry Kit:  
 R & D systems Anti-Goat HRP-DAB Cell & Tissue Staining Kit; 
Catalog Number: CTS008; Minneapolis, USA. 
 Peroxidase Blocking Reagent - 6 mL of 3% Hydrogen Peroxide 
(H2O2). 
 Avidin Blocking Reagent - 6 mL of Avidin solution, containing 
0.1% Sodium Azide (NaN3). 
 Biotin Blocking Reagent - 6 mL of Biotin solution, containing              
0.1% NaN3. 
 “Vial A” Secondary Biotinylated Antibodies  - 6 mL of either 
anti-mouse, anti-rabbit, anti-goat, anti-rat, or anti-sheep secondary 
antibodies, respectively, in 0.01 M PBS containing 0.1% NaN3. 
 “Vial B” High Sensitivity Streptavidin-HRP Conjugate           
(HSS-HRP) - 6 mL of Streptavidin conjugated to HRP in 0.01 M 
PBS containing 1% carrier protein, with preservatives and 
stabilizer. 
 DAB Chromogen - 2 mL of 2.5% 3,3-diamino benzidine (DAB) in 
stabilizing buffer. 
 DAB Chromogen Buffer - 2 vials (15 mL/vial) of 0.1% H2O2 in 
Tris HCl Buffer. 
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SLIDE PREPARATION  
Precoating procedure 
Before taking the sections onto the slide, all the slides were coated 
with APES (3 amino- propyl tri- ethoxysilane). Pre coating procedure of the 
slides was as follows: 
 Slides were first washed in tap water for few minutes. 
 They were then soaked in detergent solution (Laxbro) for an hour. 
 After 1 hour each slide was brushed individually using the detergent 
solution and was transferred to distilled water. 
 Slides were washed in two changes of distilled water. 
 Later slides were washed in autoclaved distilled water. 
 The slides were then immersed in 1 N HCl overnight. 
 The following day the slides were washed in two changes of 
autoclaved distilled water. 
 All the slides were then transferred to slide trays, wrapped in 
aluminum foil and baked in hot air oven for 4 hours at 180⁰C. 
APES coating procedure: 
The slides were allowed to cool down and were then coated with APES 
using the following procedure. 
 Slides were dipped in a Coplin jar containing acetone for 2 minutes. 
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 The slides were then dipped in a Coplin jar containing APES for 5 minutes. 
 Following this, the slides were dipped in two changes of distilled water for 2 
minutes each to remove excess APES and were left to dry. 
TISSUE SECTIONING 
 The paraffin embedded tissues were sectioned approximately 4 microns thick 
using a manual rotary  microtome.  
 The sections were placed in a water bath containing deionized distilled water 
preheated to 40-44ºC to   remove micro-wrinkles. 
 Two tissue sections were placed flat, wrinkle and fold free on the APES 
pretreated microscope slides. 
 Tissue sections were dried by placing on a slide warming table at 100⁰C for 60 
minutes. 
IMMUNOHISTOCHEMISTRY (IHC) PROCEDURE 
Positive control 
            Prostrate cancer tissue was used as positive control. 
Negative control 
 Gingival tissue to which primary antibody was not added, was used as 
negative control. 
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 Immunohistochemistry procedure was carried out using R&D systems 
IHC protocol. 
Deparaffinisation of tissues sections 
 The slides with tissue sections were heated on a slide warming table at 
100˚C for 2 minutes. The slides were treated with two changes of xylene to 
remove paraffin wax. They were put in descending grades of alcohol and then 
rehydrated with Phosphate Buffered Saline (PBS). Circles were drawn around 
the tissues, so that the antibodies added later did not spread and were restricted 
to the circle. 
Antigen Retrieval  
 The slides were then transferred in a coplin jar containing EDTA 
buffer
 
and antigen retrieval was done in an autoclave at a temperature of 
121°C and pressure of 20 psi for 15 minutes. Then the slides were allowed to 
cool till it reached room temperature.  
Staining procedure 
 The slides were treated with 3% hydrogen peroxide for 15 minutes to 
quench endogenous peroxidase activity of cells that would otherwise result in 
non – specific staining. The slides were put in one change of PBS. Slides were 
then treated with avidin blocking agent (R&D systems, CTS008, Minneapolis, 
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USA) for 15 minutes. Slides were rinsed in PBS following which the slides 
were treated with biotin blocking agent for 15 minutes. Avidin and biotin 
blocking agents were used to suppress endogenous avidin binding activity 
(EABA). Slides were again rinsed in PBS. 
 The primary antibody B7-H3 (R&D systems, AF1027, Minneapolis, 
USA) was added to the tissue on the slides. The stainless steel tray with glass 
rods containing the slides was incubated overnight at 2-8℃. The slides taken 
out were washed in three changes of cold PBS for 5 minutes each, to remove 
the excess antibody. Then the slides were wiped carefully without touching the 
tissue section to remove excess PBS. Then 1-3 drops of biotinylated secondary 
antibody (R&D systems, CTS008, Minneapolis, USA) was added onto the 
sections and the slides were incubated for 1 hour. Later the slides were washed 
in three changes of cold PBS for 15 minutes each. The slides were again 
wiped carefully without touching the tissue section to remove excess PBS. 
Then 1-3 drops of HSS- HRP from the secondary antibody kit (R&D systems, 
CTS008, Minneapolis, USA) was added onto the sections and the slides were 
incubated for 30 minutes. The sections were then washed in three changes of 
cold PBS for 2 minutes each. Then the slides were again wiped carefully to 
remove excess PBS. Then a drop of freshly prepared DAB (diamino benzidine 
– a substrate Chromogen) (R&D systems, CTS008, Minneapolis, USA) was 
added onto the sections and incubated for 15 minutes. Slides were then 
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washed in three changes of PBS for 10 minutes each and then rinsed in 
distilled water to remove excess DAB and counter stained with Harris’s 
Haematoxylin. They were then washed with alcohol and xylene. The tissue 
sections were mounted with DPX.  Throughout the procedure, care was taken 
not to dry the tissues.   
Observation: 
 All the slides were viewed under the light microscope at magnification 
10x and 40x. The slides were checked for positive staining in the tissue 
sections. The strong brown membranous immunostaining exhibited by the 
gingival tissue was taken to be positive. Thus the intensity of staining (in 
epithelium) and the number of cells (counted in the connective tissue) was 
recorded. 
 Positively stained cells were seen in the basal layers of oral gingival 
epithelium in all the slides examined. The intensity of staining was observed 
by two examiners and graded as Negative (-), Mild (+), Moderate (++) and 
Intense (+++). The inter-examiner variation was determined by kappa 
analysis.  
 In the connective tissue positive stain was uniformly identified in the 
cells present just beneath the basement membrane. The number of positive 
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cells in the connective tissue was manually counted using Coulter’s chamber 
and the mean labeling index was calculated. 
                                            Number of positive cells        
                         LI   =   ---------------------------------------- × 100 
                                                          1000 
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IHC PROCEDURE FLOW CHART 
APES coated slides with sections 
preheated on slide warming table (100⁰C;2mins) 
 
Placed in xylene I (10 min) 
 
Placed in xylene II (10 min) 
 
Placed in 100% isopropanol (10 min) 
 
Placed in 70% isopropanol (5 min) 
 
Placed in 50% isopropanol (5 min) 
 
Washed in PBS (10 mins) 
 
Kept in EDTA buffer and autoclaved (20 psi;15 mins) 
 
Cooled to room temperature  
 
Placed in 3% hydrogen peroxide (15 min) 
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Washed in PBS once (5 min) 
 
 
1-3 drops avidin blocking agent added (15 min) 
 
Rinsed in PBS 
1-3 drops biotin blocking agent added (15 min) 
 
Rinsed in PBS 
 
Primary antibody added & incubated for overnight at 2-8⁰C 
 
 
Washed thrice in PBS (5 mins) 
 
 
Incubated with 1-3 drops of biotinylated secondary antibody (1 hour) 
 
                       
Washed thrice in PBS (15 min) 
 
Incubated with 1-3 drops of HSS- HRP (30 mins) 
 
Washed thrice in PBS (2 min) 
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DAB was added and incubated (15 min) 
 
 
Washed with PBS thrice (10 min) 
 
 
Rinsed  in distilled water (5 min) 
 
 
Stained with haematoxylin (30 seconds) 
 
 
Washed in distilled water 
 
 
Placed in 70% isopropanol (5 min) 
 
 
Placed in 100% isopropanol (5 min) 
 
Placed in xylene (5 min) 
 
 
Slides were mounted using DPX 
 
Slides were observed under the microscope 
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STATISTICAL ANALYSIS 
Data entry and descriptive analysis was performed using SPSS version 
10.0.5. Mean LI and standard deviation was calculated to assess
 
B7-H3 
expression.
  
 The intensity of staining was determined by two examiners and the inter-
examiner variation was determined by kappa analysis.
 
 Independent ‘t’ test was used to compare the two groups, (Healthy and 
Chronic Periodontitis) with regard to the B7-H3 expression.
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RAGAS DENTAL COLLEGE AND HOSPITALS, CHENNAI. 
DEPARTMENT OF PERIODONTICS 
PROFORMA 
 
NAME:                              AGE:                          SEX:                      DATE:          
ADDRESS:                                                              OCCUPATION:                                 
OP.NO:      
 
CHIEF COMPLAINT: 
 
PAST DENTAL HISTORY: 
 
MEDICAL HISTORY: 
 
PERSONAL HABITS: 
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INTRAORAL EXAMINATION 
A. HARD TISSUE EXAMINATION: 
 
B. SOFT TISSUE EXAMINATION: 
 
- GINGIVAL FINDINGS 
 
 
 
 
 
 
- DENUDED ROOTS (MILLER’S CLASSIFICATION) 
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Measurement of Probing Depth and Clinical Attachment Loss 
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PROVISIONAL DIAGNOSIS: 
 
TREATMENT PLAN: 
 
 
 
 
 
BIOPSY DETAILS: 
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CONSENT FORM 
 I,_______________________________________s|o,w|o,d|o________
____________aged about_____years Hindu/ Christian/Muslim/____________ 
residing at _______________________________________ do hereby 
solemnly and state as follows. 
 I am the deponent herein; as such I am aware of the facts stated here 
under. 
 I state that I came to Ragas Dental College Hospital, Chennai for my 
treatment for ……………………………………………………………… 
 I was examined by Dr. ___________________________ and I was 
requested to do the following tests. 
1.  
2.  
3.  
 I was also informed and explained about the pros and cons of the 
treatment / test in the __________________ (language) known to me. 
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 I was also informed and explained that the results of the individual test 
will not be revealed to the public. I give my consent after knowing full 
consequences of the dissertation/ thesis /study and I undertake to cooperate 
with the doctor for the study. 
 I also assure that I shall come for each and every sitting without fail. 
 I also authorize the doctor to proceed with further treatment or any 
other/suitable/alternative method for the study. 
 I have given voluntary consent to undergo treatment without any 
individual pressure. 
 I am also aware that I am free to withdraw the consent at any time 
during the study in writing. 
 
Signature of the Patient/Attendant 
 The patient was explained the procedure by me and he has understood 
the same and with full consent signed in (English/ Tamil/ Hindi/ Telugu/ 
____________) before me. 
Signature of the Doctor 
 
 HEALTH GROUP (GROUP A) 
 
 
 
DISEASE GROUP (GROUP B) 
 
 
 ARMAMENTARIUM 
 
 
 
 
 
 
  
REAGENTS 
 
 
 
 
 
PRIMARY ANTIBODY 
 
 
SECONDARY ANTIBODY KIT 
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RESULTS 
 A total of 30 gingival tissue samples (15 health and 15 diseased) were 
evaluated for expression of B7-H3. (The results are summarized in Table 1 
and 2). 
Staining in epithelium  
    All the tissues were assessed for intensity of staining in gingival 
epithelium. Intense staining was observed in 5 specimens in group A and             
4 specimens in group B. Moderate staining was observed in 7 specimens in 
group A and 8 specimens in group B. Pale staining was seen in 3 specimens in 
group A and 1 specimen in group B. Brown staining was not seen in                      
2 specimens in group B. Therefore only 13 specimens in group B expressed          
B7-H3 in epithelium while all 15 specimens in group A were positive for             
B7-H3 in gingival epithelium. 
    A good inter-examiner agreement was observed between the two 
examiners (health - 0.718; disease - 0.797). 
Staining in connective tissue  
 Immunostaining of gingival connective tissue showed localization of 
B7-H3 to just beneath the basement membrane. The number of positive cells 
in lamina propria was evaluated using mean labeling index. The results of the 
mean labeling index were as follows: in group A, the mean labeling index was 
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50.28±26.09; in group B, 41.37±25.29. There was no statistically significant 
difference in the mean labeling index between the two study groups, since           
p value is >0.01 (p value = 0.415). 
 Figure 1,2,3 and 4 describes B7-H3 expression in health and disease, 
when viewed under light microscope at 10x and 40x. 
Tables & Figures 
 
 
 
Table 1. 
Tabulation of Intensity and Labeling  Index  in Gingival  Samples 
S. 
NO. 
AGE/
SEX 
SITE PPD CAL Procedure Intensity 
1 
Intensity 
2 
LI SLIDE 
NO. 
1. 21/F 13–P* 2 2 2 -   CL* ++ ++ 20 4555 
2. 49/F 36-B* 3 3 3 - CL ++ + 75.3 4521 
3. 20/F 17-B* 2 3 3 - CL +++ +++ - 4519 
4. 44/M 36-L* 3 3 3 - CL ++ + 22.2 4509 
5. 32/F 21-P 2 3 3 - CL +++ +++ 73.5 4627 
6. 24/M 16- B 2 1 2 - CL ++ ++ 75.3 4342 
7. 24/F 37-L 2 3 3 - CL +++ +++ 69.3 4464 
8. 22/M 46-L 3 2 3 - CL ++ ++ - 4437 
9. 39/M 27-B 2 2 2 - CL +++ +++ 71.9 4585 
10. 25/F 25-P 2 2 2 - CL + + 13.2 4694 
11. 21/F 46-B 3 2 3 - CL +++ +++ 18.4 4239 
12. 26/M 25-B 3 3 3 - CL + + - 4333 
13. 25/F 25-B 3 2 3 - CL ++ ++ - 4592 
14. 24/F 36-L 3 3 3 - CL ++ ++ 56.1 4234 
15. 22/F 13-P 2 2 2 - CL + + 57.9 4345 
16. 43/M 27-B 8 6 8 9  8  9   MWF* ++ + 92.6 4674 
17. 60/F 11-P 6 6 6 7  7  7 MWF +++ +++ - 4359 
18. 38/F 45-L 6 5 6 7  7  7 MWF + + 53.3 4612 
19. 48/M 47-B 10 8 8 10  9  9 MWF ++ ++ 44.7 4488 
20. 39/M 46- B 10 6 8 12  7  8 MWF ++ ++ 26.1 4327 
21. 28/F 36-B 4 2 10 6  4  11 MWF +++ +++ 29.8 4683 
22. 45/M 25-B 5 7 7 7  8  8 MWF +++ +++ 18.9 4720 
23. 55/M 23-B 6 8 8 7  10  9 MWF ++ ++ 14.3 4719 
24. 36/F 17-P 7 6 8 8  7  9 MWF ++ ++ 49.4 4443 
25. 40/F 46-L 8 6 8 9  8  9 MWF ++ ++ 31.4 4554 
26. 58/M 16 –B 7 10 8 9  10  9 MWF - - -ve* 4711 
27. 37/F 46-L 6 4 6 7  5  7 MWF - + -ve 4344 
28. 37/F 16- B 8 8 8 10  9  9 MWF +++ +++ 26.3 4247 
29. 43/M 16- P 9 9 7 10  11  8 MWF ++ ++ 85.7 4499 
30. 48/F 34-B 9 7 9 10  9  10 MWF ++ ++ 24.0 4540 
*B- Buccal, L- Lingual, P- Palatal, CL- Crown Lengthening, MWF- modified 
Widman flap, -ve- Negative 
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Table 2. 
Comparison of Intensity Scoring and Mean Labeling Index between 
Health and Disease 
 
Group A 
(health) 
Group B 
(periodontal 
disease) 
p value 
Epithelium  
(intensity) 
Intense - 5 
Moderate - 7 
Mild  – 3 
Intense – 4 
Moderate – 8 
Mild  – 1 
Negative - 2 
- 
Connective tissue 
(mean LI± SD) 
50.28± 26.09 41.37±25.29 0.415 
 
(p value <0.001-statistically significant; p value >0.001- statistically 
insignificant) 
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FIG.1: EXPRESSION OF B7-H3 IN HEALTHY GINGIVA (10x VIEW) 
 
 
FIG.2: EXPRESSION OF B7-H3 IN HEALTHY GINGIVA (40x VIEW)      
 
-  indicates positive staining 
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FIG.3: EXPRESSION OF B7-H3 IN DISEASED GINGIVA (10x VIEW) 
 
                                      
FIG.4: EXPRESSION OF B7-H3 IN DISEASED GINGIVA (40x VIEW) 
 
                                             -  indicates positive staining 
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DISCUSSION 
Progression of periodontal disease is episodic in nature characterized by 
short bursts of disease activity followed by a long quiescent phase.
53 
This 
pattern of disease progression is thought to be influenced by the host response, 
triggered by periodontopathogenic bacteria.  
The role of T cells in regulating immune response is well documented. 
They are crucial for progression and control of chronic inflammation,
100,161
 
and have been implicated in the pathogenesis of periodontal disease. Optimal 
T cell function requires a set of stimulatory and inhibitory signal in addition to 
antigen presentation.   
Earlier studies by Gemmell E et al (2002)
49
 on B7 molecule expression 
were based on the premise that, costimulatory molecule are primarily 
expressed on professional APC leading to activation of T cells. Present 
evidence suggests that non-immune cells may also express costimulatory 
molecules. Previous studies in mouse models and humans
23,147,73,138,156,162,29
 
have identified B7-H3 as a newly discovered co-stimulatory molecule of B7 
family. It is an important regulator of T cell function and their results provided 
the basis for our present study.  
Several authors have reported B7-H3 expression to be induced in 
immune cells such as B cells, monocytes, dendritic cells and                                  
T cells
134,23,136,138,165
 and by nonimmune cells such as fibroblast-like 
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synoviocytes and epithelial cells.
61
 Though, there exists contradictory 
evidence for the role of B7-H3 in T cell function, recent evidence suggests an 
inhibitory role.
19,135,147,73,83
 
 The present study was undertaken to clarify if there is any quantifiable 
difference in expression of B7-H3 in healthy and diseased gingival specimens. 
To our knowledge this is the first study to assess the expression of B7-H3 in 
gingival tissues. The study comprised of 30 patients (15 health, 15 disease) 
who were randomly selected from those attending the outpatient clinic of 
Ragas dental college and divided into two groups as  Group A (healthy 
periodontal tissue as characterised by PD< 3mm and BOP<10% of sites) and 
Group B (diseased periodontal tissue as characterized by  PD ≥5mm and 
CAL≥ 3mm).  
In group A, gingival tissue was excised during crown lengthening 
procedures while in group B it was removed one week after scaling and root 
planing, while carrying out the modified Widman flap procedure. Biopsy 
specimens obtained were fixed in 10% formalin and paraffinised within 48 
hours. Antigen retrieval was carried out using EDTA buffer (pH8). Staining 
was carried out under standardized temperature and time. The slides were 
viewed under light microscope at magnification 10x and 40x. Presence of 
brown membrane staining on the cells was taken as positive. The staining was 
evaluated based on intensity in the epithelium and labeling index in connective 
tissue.  
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B7-H3 molecule was examined as: 
 cell surface marker 
 speculated to play an active role in regulation of  T cell  
  activation as previously reported.
23,83,90,116,134, 135,147
 
 Results of the present study revealed that B7-H3 is expressed in 
gingival tissue. In the epithelium positive staining was confined to the basal 
layer. The intensity of staining ranged from intense to moderate and there was 
no difference in intensity of staining between the groups. In the connective 
tissue, the staining was observed close to the basement membrane. Our results 
demonstrated, in the connective tissue a statistically insignificant decrease          
(p value = 0.415) in diseased specimens (41.37±25.29) when compared to 
healthy specimens (50.28±26.09). 
The results of the present study could be speculated as follows: 
The gingiva provides the first line of defense in protection against 
invading pathogens.
149,25,120
 In health, B7-H3 expression may provide signals 
for increased basal inflammatory tone in response to commensal bacterial 
antigen. The need for this basal inflammatory tone arises from the fact that 
putative pathogens may also be present in health, which has to be eliminated.    
 In disease the decreased expression of B7-H3, could be due to B7-H3 
being used up during regulation of T cell function. Conversely it can also be 
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argued that continous antigenic stimulation may lead to downregulation of 
peripheral tolerance mechanisms.    
 Earlier studies have revealed the expression of other members of B7 
family. Increased expression of B7-1 and B7-2 has been reported in diseased 
periodontal specimens.
110,46,26,96
 Figueira et al (2009)
40
 showed that blockade 
of PD-1 resulted in upregulation of  IFN-γ by T cells in periodontal disease. 
Our study is in agreement with studies carried out in gastric 
carcinoma
156,162
 and pancreatic cancer
85
 which reveal a decreased expression 
of B7-H3 in disease. These studies correlate elevated B7-H3 expression with 
an increased survival rate in patients.  
B7-H3 has been found to play a contrasting role in other chronic 
inflammatory diseases. Tran et al (2008)
147
 examined synovial tissue from RA 
patients. They found maximum B7-H3 expression in lining layer of RA 
synovium. Suh et al (2003)
135
 in murine studies using B7-H3 knockout mice 
revealed increasing severity of airway inflammation and increased T cell 
infiltration. Kim J et al (2005)
73
 examined B7-H3 expression in nasal 
epithelial cells of patients diagnosed with asthma and chronic rhinosinusitis. 
They reported increased expression of B7-H3 with increasing severity of 
disease. Healthy and chronic rhinosinusitis tissue samples revealed negative or 
mild staining while intense staining was found in tissue from patients 
diagnosed with asthma. Expression of B7-H3 has been evaluated by a number 
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of authors in prostrate cancer.
162,122
 They have found that increasing 
expression of B7-H3 in the specimens correlates with an increased severity of 
disease and probability of recurrence.  
At present factors determining disease progression are not well 
characterized. Presence or absence of tolerance has been implicated in disease 
progression. Our results indicate B7-H3 does play a role in pathogenesis of 
periodontal disease.  
The clinical implication based on the results of our study is that, 
increased expression of B7-H3 may be protective, as it prevents excessive 
inflammatory response. Hence it can be used in host modulation therapies to 
regulate T cells function. 
Limitations of this study include that antibodies only against B7-H3 
molecule were used, as a result does not reveal the cells which express this 
molecule. The small sample size of this study could also be a reason for the 
statistically insignificant decrease in B7-H3 expression in diseased specimens.   
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SUMMARY AND CONCLUSION 
 This study was carried out to evaluate the expression of B7-H3 in 
healthy and diseased gingival tissue samples. 
 15 healthy and 15 diseased gingival biopsy specimens were obtained at 
random from patients attending the outpatient clinic in Ragas Dental College. 
These specimens were paraffinised and processed. The thin sections obtained 
were subjected to immunostaining and slides were viewed under light 
microscope to evaluate brown staining, indicative of B7-H3 expression. In 
epithelium intensity of staining was examined while number of positive cells 
was counted in connective tissue. 
Staining in epithelium was found in basal layer, ranged from moderate 
to intense with no significant variation between healthy and diseased 
specimens. It was evaluated by 2 examiners to remove bias. Kappa analysis 
revealed good inter-examiner agreement (health - 0.718; disease - 0.797). In 
the connective tissue staining was found adjacent to basement membrane with 
a statistically insignificant (p = 0.415) decrease in positive cells from health 
(50.28±26.09) to disease (41.37±25.29). 
 This study demonstrates decreased expression of B7-H3 in             
diseased as compared to healthy gingival samples. This difference between the 
two groups was statistically insignificant. More number of cases with 
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statistically significant data is essential to prove its use in host modulation 
therapy and also to regulate T cell function as a whole. 
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